Multiple sclerosis in Italy: cost-of-illness study
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : F. Patti • M. P. Amato • M. Trojano • C. Solaro • A. Pappalardo • V. Zipoli • E. Portaccio • D. Paolicelli • A. Paolillo • F. S. Mennini • A. Marcel
- چاپ و سال / کشور: 2011
Description
This study estimates the direct costs of multiple sclerosis (MS) in Italy from the perspective of the National Health System. Patients diagnosed with MS for C1 year prior to study entry were included in the analysis; neurological disability was assessed using the Expanded Disability Status Scale (EDSS). Cost variables were analyzed according to: MS phenotype, disease course over the previous year and EDSS rating. A total of 510 patients were included in the analysis. Overall costs were significantly higher for relapsing-remitting MS and secondary progressive MS than for primary progressive MS (P\0.05). Costs were higher for EDSS scores 0.0–3.5 and 4.0–6.0 than for scores[6.0 (P\0.05). The extrapolated data gave an estimated annual direct cost of MS per patient of €18,030. In conclusion, relapsing-remitting MS or secondary progressive MS phenotypes and lower estimated EDSS scores appear to be associated with higher costs.
Neurol Sci DOI 10.1007/s10072-011-0499-2 Received: 14 September 2010 / Accepted: 16 February 2011
